DKMA Update December 2018
Updated 23 January 2019
This newsletter features the following articles:
Editorial
- The safety of medical devices is strengthened
Latest news about medicines safety and medical devices
- Further restrictions on the use of valproate
- Risk of suicide to be reflected in the product information of contraceptive pills
- Restricted use of antibiotics with quinolones and fluoroquinolones is advised
- Stricter dose warning on the package of the arthritis and psoriasis medicine methotrexate
- New biosimilar medicines for Humira
An insight into the work of the Danish Medicines Agency in 2018
- New growth plan boosted the Danish Medicines Agency’s ambition to join Europe’s best in class
- Danish Medicines Agency part of inspection agreement between EU and the USA in 2018
- Concerted campaign on safe online shopping received with great interest
- Impurities found in several batches of blood pressure lowing medicine valsartan
- A Danish registry study found a small increased risk of two forms of cancer with the use of hydrochlorothiazide
- High turnout for theme events at the Danish Medicines Agency
- Tonnes seized in global operation against illegal online sale of medicines
- Danish Medicines Agency strengthened its international collaboration
- Danish Medicines Agency represented at World Economic Forum
- Top marks for the Danish Medicines Agency in European survey
- Danish Medicines Agency launched a new concept for national scientific advice
- Work began on a new register of medicinal products to benefit patient safety
- Major efforts for safer prescription of blood thinning medicines
- Better conditions for clinical trials in Denmark
- European top post for Thomas Senderovitz
- Medicinal cannabis pilot programme entered into force
Two projects with focus on companies
- Pharmaceutical companies must ensure people have access to package leaflets on www.indlaegsseddel.dk
- Major European review of the subdivision of tablets
Short news
- New front page for our website
- Brexit page on the website of the Danish Medicines Agency
- Major international focus on the reporting of suspected adverse reactions
- Thank you for your cooperation and dedication in 2018